Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep/Oct;42(5):688-696.
doi: 10.1097/RCT.0000000000000754.

Diagnostic Value of Diffusion-Weighted Imaging and Apparent Diffusion Coefficient in Assessment of the Activity of Crohn Disease: 1.5 or 3 T

Diagnostic Value of Diffusion-Weighted Imaging and Apparent Diffusion Coefficient in Assessment of the Activity of Crohn Disease: 1.5 or 3 T

Ahmed Abd-El Khalek Abd-ALRazek et al. J Comput Assist Tomogr. 2018 Sep/Oct.

Abstract

Objective: The objective of this study is to evaluate the role of diffusion-weighted imaging (DWI) in assessment of the activity of Crohn disease (CD) and to explore differences between DWI in 3 T and 1.5 T.

Methods: Postcontrast magnetic resonance enterography with DWI of 72 patients with pathological proof of CD was retrospectively evaluated for restricted diffusion qualitatively and quantitavely in 3 T (n = 40) and 1.5 T (n = 32). Magnetic resonance activity score of 7 or higher was used as reference of activity.

Results: Fifty-five patients had active lesions. Diffusion-weighted imaging hyperintensity showed sensitivity (100%, 100%) and specificity (88.89%, 100%) in 1.5/3 T for activity assessment. Mean ± SD apparent diffusion coefficient for active lesions was 1.21 ± 0.42 and 1.28 ± 0.59 × 10 mm/s in 1.5 and 3 T, respectively. The proposed cutoff values of 1.35 and 1.38 × 10 mm/s in 1.5 and 3 T, respectively, had sensitivity (80%, 93%), specificity (100%, 90%), accuracy (88%, 93%), and no significant difference in accuracy between 1.5/3 T (P = 0.48).

Conclusions: Diffusion-weighted imaging hypersensitivity and apparent diffusion coefficient values accurately assessed the activity of CD. No significant statistical difference in diagnostic accuracy was detected between 1.5 and 3 T.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interests.

Figures

FIGURE 1
FIGURE 1
A 19-year-old female with active CD of terminal ileum. A, The axial T2- and (B) contrast-enhanced T1-weighted images show marked mural T2 hyperintensity and contrast enhancement with thickened bowel wall in the terminal ileum (white arrows). Grade 3 hyperintensity on the axial diffusion-weighted MRI with b = 800 s/mm2 (white arrow in C) and hypointensity on corresponding ADCs map (black arrow in D). The mean ADC in the inflamed bowel wall to be 0.66 × 10−3 mm2/s.
FIGURE 2
FIGURE 2
A 31-year-old female with inactive CD. A, The axial T2- and (B) contrast-enhanced T1-weighted images showed mural thickness of terminal ileum (3 mm). Grade 2 hyperintensity on the axial diffusion-weighted MRI with b = 800 s/mm2 (white arrow in C), yet no significant hypointensity on corresponding ADCs map (white arrow in D). The mean ADC in the inflamed bowel wall to be 1.8 × 10−3 mm2/s.
FIGURE 3
FIGURE 3
Receiver operating characteristics curve of DWI hyperintensity in 1.5 T; area under the ROC curve, 0.99. Figure 3 can be viewed online in color at www.jcat.org.
FIGURE 4
FIGURE 4
Receiver operating characteristics curve of DWI hyperintensity in 3 T; area under the ROC curve, 1. Figure 4 can be viewed online in color at www.jcat.org.
FIGURE 5
FIGURE 5
Receiver operating characteristics curve of mean ADC in 1.5 T; area under the ROC curve, 0.97. Figure 5 can be viewed online in color at www.jcat.org.
FIGURE 6
FIGURE 6
Receiver operating characteristics curve of mean ADC in 3 T; area under the ROC curve, 0.98. Figure 6 can be viewed online in color at www.jcat.org.

Similar articles

Cited by

References

    1. Peyrin-Biroulet L, Loftus EV, Jr, Colombel JF, et al. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol. 2010;105:289–297. - PubMed
    1. Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis. 2010;4:28–62. - PubMed
    1. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology. 2002;122:512–530. - PubMed
    1. Daperno M, D'Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc. 2004;60:505–512. - PubMed
    1. Bourreille A, Ignjatovic A, Aabakken L, et al. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy. 2009;41:618–637. - PubMed